Suppression and regression of choroidal neovascularization in mice by a novel CCR2 antagonist, INCB3344

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Xie, Ping ^a   Kamei, Motohiro ^a   Suzuki, Mihoko ^a   Matsumura, Nagakazu ^a   Nishida, Kentaro ^a   Sakimoto, Susumu ^a   Sakaguchi, Hirokazu ^a   Nishida, Kohji ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1/2; MW5776; N [2 [[1 [4 (1,3 BENZODIOXOL 5 YL) 4 HYDROXYCYCLOHEXYL] 4 ETHOXY 3 PYRROLIDINYL]AMINO] 2 OXOETHYL] 3 (TRIFLUOROMETHYL)BENZAMIDE; PF 418725; UNCLASSIFIED DRUG; VASCULOTROPIN; CHEMOKINE RECEPTOR CCR2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PYRROLIDINE DERIVATIVE; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GROWTH INHIBITION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LASER COAGULATION; MACROPHAGE; MALE; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PIGMENT EPITHELIUM; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SUBRETINAL NEOVASCULARIZATION; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LASER; METABOLISM; PHOSPHORYLATION;

ANIMALS; CHOROIDAL NEOVASCULARIZATION; GENE EXPRESSION REGULATION; LASERS; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; PYRROLIDINES; RECEPTORS, CCR2; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 83655183735     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028933     Document Type: Article

References (51)

1. Fine SL, Berger JW, Maguire MG, Ho AC, (2000) Age-related macular degeneration. N Engl J Med 342: 483-492.
2. Yamada K, Sakurai E, Itaya M, Yamasaki S, Ogura Y, (2007) Inhibition of laser-induced choroidal neovascularization by atorvastatin by downregulation of monocyte chemotactic protein-1 synthesis in mice. Invest Ophthalmol Vis Sci 48: 1839-1843.
3. Grossniklaus HE, Green WR, (2004) Choroidal neovascularization. Am J Ophthalmol 137: 496-503.
4. Tsutsumi-Miyahara C, Sonoda KH, Egashira K, Ishibashi M, Qiao H, et al. (2004) The relative contributions of each subset of ocular infiltrated cells in experimental choroidal neovascularisation. Br J Ophthalmol 88: 1217-1222.
5. Grossniklaus HE, Ling JX, Wallace TM, Dithmar S, Lawson DH, et al. (2002) Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. Mol Vis 8: 119-126.
6. Kamei M, Yoneda K, Kume N, Suzuki M, Itabe H, et al. (2007) Scavenger receptors for oxidized lipoprotein in age-related macular degeneration. Invest Ophthalmol Vis Sci 48: 1801-1807.
7. Ferrara N, Davis-Smyth T, (1997) The biology of vascular endothelial growth factor. Endocr Rev 18: 4-25.
8. Xiong M, Elson G, Legarda D, Leibovich SJ, (1998) Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway. Am J Pathol 153: 587-598.
9. Yi X, Ogata N, Komada M, Yamamoto C, Takahashi K, et al. (1997) Vascular endothelial growth factor expression in choroidal neovascularization in rats. Graefes Arch Clin Exp Ophthalmol 235: 313-319.
10. Ishibashi T, Hata Y, Yoshikawa H, Nakagawa K, Sueishi K, et al. (1997) Expression of vascular endothelial growth factor in experimental choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol 235: 159-167.
11. Espinosa-Heidmann DG, Suner IJ, Hernandez EP, Monroy D, Csaky KG, et al. (2003) Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 44: 3586-3592.
12. Sakurai E, Anand A, Ambati BK, van Rooijen N, Ambati J, (2003) Macrophage depletion inhibits experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 44: 3578-3585.
13. Furie MB, Randolph GJ, (1995) Chemokines and tissue injury. Am J Pathol 146: 1287-1301.
14. Strieter RM, Standiford TJ, Huffnagle GB, Colletti LM, Lukacs NW, et al. (1996) "The good, the bad, and the ugly." The role of chemokines in models of human disease. J Immunol 156: 3583-3586.
15. Power CA, Proudfoot AE, (2001) The chemokine system: novel broad-spectrum therapeutic targets. Curr Opin Pharmacol 1: 417-424.
16. Tsutsumi C, Sonoda KH, Egashira K, Qiao H, Hisatomi T, et al. (2003) The critical role of ocular-infiltrating macrophages in the development of choroidal neovascularization. J Leukoc Biol 74: 25-32.
17. Benny O, Nakai K, Yoshimura T, Bazinet L, Akula JD, et al. (2010) Broad Spectrum Antiangiogenic Treatment for Ocular Neovascular Diseases. PLoS One 5: e12515.
18. Chen H, Liu B, Lukas TJ, Neufeld AH, (2008) The aged retinal pigment epithelium/choroid: a potential substratum for the pathogenesis of age-related macular degeneration. PLoS One 3: e2339.
19. Noda K, She H, Nakazawa T, Hisatomi T, Nakao S, et al. (2008) Vascular adhesion protein-1 blockade suppresses choroidal neovascularization. FASEB J 22: 2928-2935.
20. Satofuka S, Ichihara A, Nagai N, Noda K, Ozawa Y, et al. (2008) (Pro)renin receptor promotes choroidal neovascularization by activating its signal transduction and tissue renin-angiotensin system. Am J Pathol 173: 1911-1918.
21. Guymer RH, Tao LW, Goh JK, Liew D, Ischenko O, et al. (2011) Identification of urinary biomarkers for age-related macular degeneration. Invest Ophthalmol Vis Sci 52: 4639-4644.
22. Jonas JB, Tao Y, Neumaier M, Findeisen P, (2010) Monocyte chemoattractant protein 1, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1 in exudative age-related macular degeneration. Arch Ophthalmol 128: 1281-1286.
23. Kuziel WA, Morgan SJ, Dawson TC, Griffin S, Smithies O, et al. (1997) Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc Natl Acad Sci U S A 94: 12053-12058.
24. Kurihara T, Warr G, Loy J, Bravo R, (1997) Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J Exp Med 186: 1757-1762.
25. Lu B, Rutledge BJ, Gu L, Fiorillo J, Lukacs NW, et al. (1998) Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein-1-deficient mice. J Exp Med 187: 601-608.
26. Brodmerkel CM, Huber R, Covington M, Diamond S, Hall L, et al. (2005) Discovery and pharmacological characterization of a novel rodent-active CCR2 antagonist, INCB3344. J Immunol 175: 5370-5378.
27. Shin N, Baribaud F, Wang K, Yang G, Wynn R, et al. (2009) Pharmacological characterization of INCB3344, a small molecule antagonist of human CCR2. Biochem Biophys Res Commun 387: 251-255.
28. Dansereau MA, Gosselin RD, Pohl M, Pommier B, Mechighel P, et al. (2008) Spinal CCL2 pronociceptive action is no longer effective in CCR2 receptor antagonist-treated rats. J Neurochem 106: 757-769.
29. Intyte (2006) CCR2 ANTAGONIST PROGRAM. Orally-Administered Therapeutics for Inflammation-Driven Diseases. Available: http://www.incyte.com/backgrounders/A%20CCR2%20Backgrounder.pdf.
30. Luhmann UF, Robbie S, Munro PM, Barker SE, Duran Y, et al. (2009) The drusenlike phenotype in aging Ccl2-knockout mice is caused by an accelerated accumulation of swollen autofluorescent subretinal macrophages. Invest Ophthalmol Vis Sci 50: 5934-5943.
31. Campa C, Kasman I, Ye W, Lee WP, Fuh G, et al. (2008) Effects of an anti-VEGF-A monoclonal antibody on laser-induced choroidal neovascularization in mice: optimizing methods to quantify vascular changes. Invest Ophthalmol Vis Sci 49: 1178-1183.
32. Imamura Y, Noda S, Hashizume K, Shinoda K, Yamaguchi M, et al. (2006) Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: a model of age-related macular degeneration. Proc Natl Acad Sci U S A 103: 11282-11287.
33. Itaya M, Sakurai E, Nozaki M, Yamada K, Yamasaki S, et al. (2007) Upregulation of VEGF in murine retina via monocyte recruitment after retinal scatter laser photocoagulation. Invest Ophthalmol Vis Sci 48: 5677-5683.
34. Curry JM, Eubank TD, Roberts RD, Wang Y, Pore N, et al. (2008) M-CSF signals through the MAPK/ERK pathway via Sp1 to induce VEGF production and induces angiogenesis in vivo. PLoS One 3: e3405.
35. Koto T, Nagai N, Mochimaru H, Kurihara T, Izumi-Nagai K, et al. (2007) Eicosapentaenoic acid is anti-inflammatory in preventing choroidal neovascularization in mice. Invest Ophthalmol Vis Sci 48: 4328-4334.
36. Caicedo A, Espinosa-Heidmann DG, Piña Y, Hernandez EP, Cousins SW, (2005) Blood-derived macrophages infiltrate the retina and activate Muller glial cells under experimental choroidal neovascularization. Exp Eye Res 81: 38-47.
37. Izumi-Nagai K, Nagai N, Ohgami K, Satofuka S, Ozawa Y, et al. (2007) Macular pigment lutein is antiinflammatory in preventing choroidal neovascularization. Arterioscler Thromb Vasc Biol 27: 2555-2562.
38. Goyal S, Chauhan SK, Zhang Q, Dana R, (2009) Amelioration of murine dry eye disease by topical antagonist to chemokine receptor 2. Arch Ophthalmol 127: 882-887.
39. Krzystolik MG, Afshari MA, Adamis AP, Gaudreault J, Gragoudas ES, et al. (2002) Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. Arch Ophthalmol 120: 338-346.
40. Kvanta A, Algvere PV, Berglin L, Seregard S, (1996) Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. Invest Ophthalmol Vis Sci 37: 1929-1934.
41. Wang J, Ohno-Matsui K, Yoshida T, Shimada N, Ichinose S, et al. (2009) Amyloid-beta up-regulates complement factor B in retinal pigment epithelial cells through cytokines released from recruited macrophages/microglia: Another mechanism of complement activation in age-related macular degeneration. J Cell Physiol 220: 119-128.
42. Cousins SW, Espinosa-Heidmann DG, Csaky KG, (2004) Monocyte activation in patients with age-related macular degeneration: a biomarker of risk for choroidal neovascularization? Arch Ophthalmol 122: 1013-1018.
43. Oh H, Takagi H, Takagi C, Suzuma K, Otani A, et al. (1999) The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes. Invest Ophthalmol Vis Sci 40: 1891-1898.
44. Inoue Y, Yanagi Y, Matsuura K, Takahashi H, Tamaki Y, et al. (2007) Expression of hypoxia-inducible factor 1alpha and 2alpha in choroidal neovascular membranes associated with age-related macular degeneration. Br J Ophthalmol 91: 1720-1721.
45. Sodhi A, Biswas SK, (2002) Monocyte chemoattractant protein-1-induced activation of p42/44 MAPK and c-Jun in murine peritoneal macrophages: a potential pathway for macrophage activation. J Interferon Cytokine Res 22: 517-526.
46. Wain JH, Kirby JA, Ali S, (2002) Leucocyte chemotaxis: Examination of mitogen-activated protein kinase and phosphoinositide 3-kinase activation by Monocyte Chemoattractant Proteins-1,-2,-3 and-4. Clin Exp Immunol 127: 436-444.
47. Yen H, Zhang Y, Penfold S, Rollins BJ, (1997) MCP-1-mediated chemotaxis requires activation of non-overlapping signal transduction pathways. J Leukoc Biol 61: 529-532.
48. Cambien B, Pomeranz M, Millet MA, Rossi B, Schmid-Alliana A, (2001) Signal transduction involved in MCP-1-mediated monocytic transendothelial migration. Blood 97: 359-366.
49. Liu S, Yang P, Kang H, Lu L, Zhang Y, et al. (2010) NDRG2 induced by oxidized LDL in macrophages antagonizes growth factor productions via selectively inhibiting ERK activation. Biochim Biophys Acta 1801: 106-113.
50. Hashizume K, Hirasawa M, Imamura Y, Noda S, Shimizu T, et al. (2008) Retinal dysfunction and progressive retinal cell death in SOD1-deficient mice. Am J Pathol 172: 1325-1331.
51. Ambati J, Anand A, Fernandez S, Sakurai E, Lynn BC, et al. (2003) An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nat Med 9: 1390-1397.